The Chemours Co (CC) Position Boosted by Dynamic Technology Lab Private Ltd

Korea Investment CORP now owns 162,600 shares of the specialty chemicals company's stock worth $6,166,000 after purchasing an additional 81,200 shares in the last quarter.

Among 8 analysts covering Chemours (NYSE:CC), 6 have Buy rating, 0 Sell and 2 Hold. Zacks Investment Research raised shares of Chemours from a "hold" rating to a "strong-buy" rating and set a $38.00 price objective on the stock in a report on Thursday, February 16th. Citigroup upgraded The Chemours Company (NYSE:CC) on Wednesday, July 5 to "Buy" rating. UBS lifted their price target on shares of Chemours from $50.00 to $59.00 and gave the company a "neutral" rating in a research note on Friday, November 3rd. Jefferies downgraded the shares of CC in report on Tuesday, February 16 to "Hold" rating. Finally, Argus reaffirmed a buy rating and set a $55.00 target price (up from $50.00) on shares of Chemours in a research report on Thursday, August 10th. Jefferies has "Buy" rating and $48 target.

Shares of Chemours Company (CC) traded down $2.95 during mid-day trading on Wednesday, reaching $46.35. Chemours has a 52-week low of $20.76 and a 52-week high of $58.08. The Chemours Company (CC) now has 185160 shares outstanding, which means that its market capitalization is $9.19B. The company has a debt-to-equity ratio of 5.07, a current ratio of 2.19 and a quick ratio of 1.63. The stock of The Chemours Company (NYSE:CC) earned "Overweight" rating by Barclays Capital on Monday, November 6. Jefferies Group analyst L. Alexander now anticipates that the specialty chemicals company will post earnings per share of $0.82 for the quarter, down from their prior forecast of $0.96. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $0.61 EPS. research analysts expect that Chemours will post 3.73 earnings per share for the current year. Chemours's quarterly revenue was up 13.3% on a year-over-year basis.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Advisors Preferred LLC purchased a new stake in Chemours during the third quarter valued at $177,000. This represents a $0.68 annualized dividend and a dividend yield of 1.43%.

Chemours announced that its Board of Directors has initiated a share buyback program on Friday, December 1st that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the specialty chemicals company to purchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its shares are undervalued.

In other Chemours news, VP Mark Newman sold 22,781 shares of the business's stock in a transaction that occurred on Friday, May 5th. The stock was acquired at an average cost of $39.10 per share, for a total transaction of $97,750.00. Following the sale, the insider now directly owns 63,063 shares of the company's stock, valued at approximately $3,358,104.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The shares were sold at an average price of $53.25, for a total transaction of $632,503.50. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 50,183 shares of company stock valued at $2,720,166. Public Employees Retirement Association of Colorado grew its stake in Chemours by 17.2% in the second quarter. Public Employees Retirement System of OH now owns 98,590 shares of the specialty chemicals company's stock valued at $3,739,000 after purchasing an additional 74,329 shares during the period. Renaissance Technologies LLC increased its position in Chemours by 10.3% in the 2nd quarter. Renaissance Technologies LLC now owns 3,342,200 shares of the specialty chemicals company's stock valued at $126,736,000 after acquiring an additional 310,800 shares in the last quarter. Bank of New York Mellon Corp increased its position in Chemours by 7.9% in the 3rd quarter. World Asset Management Inc now owns 15,652 shares of the specialty chemicals company's stock worth $594,000 after purchasing an additional 597 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. now owns 42,669 shares of the specialty chemicals company's stock valued at $1,618,000 after purchasing an additional 30,970 shares during the period. Institutional investors and hedge funds own 74.42% of the company's stock.